Wendy Comisar
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Merck (Germany)(DE)United States Military Academy(US)
Publications by Year
Research Areas
Antifungal resistance and susceptibility, Bone health and osteoporosis research, HIV Research and Treatment, Parathyroid Disorders and Treatments, HIV/AIDS drug development and treatment
Most-Cited Works
- → A Single Supratherapeutic Dose of Vorinostat Does Not Prolong the QTc Interval in Patients with Advanced Cancer(2009)48 cited
- → Pharmacokinetics and safety of twice-daily atazanavir 300 mg and raltegravir 400 mg in healthy individuals(2010)31 cited
- → Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants(2010)31 cited
- → A semimechanistic model of the time-course of release of PTH into plasma following administration of the calcilytic JTT-305/MK-5442 in humans(2013)12 cited
- → Caspofungin exposure‐response relationships in adult patients with mucosal or invasive candidiasis(2013)1 cited